Curated News
By: NewsRamp Editorial Staff
September 29, 2026
Nanox.AI Expands UK Reach and Local AI Inference with Intel
TLDR
- Nanox.AI gains exclusive UK reseller deal with Vertec Scientific, securing minimum annual license commitments for its HealthOST bone solution.
- The HealthOST bone solution analyzes routine CT scans to detect vertebral fragility fractures, with Intel optimization enabling local inference on hospital hardware.
- Nanox.AI's technology helps diagnose undiagnosed vertebral fractures, potentially improving care for thousands in the UK each year.
- Routine CT scans can reveal spinal and other issues beyond the original reason, and Nanox.AI's HealthOST now targets these hidden findings.
Impact - Why it Matters
This news matters because it addresses a critical gap in diagnostic imaging: the vast number of undiagnosed conditions that are visible on routine CT scans but often overlooked. By enabling AI to identify vertebral fractures and other abnormalities, Nanox.AI can help clinicians intervene earlier, potentially preventing further complications and improving patient outcomes. The UK reseller agreement with Vertec Scientific means that this technology will become more accessible to healthcare providers in a market where 86,000 vertebral fragility fractures occur annually, most undiagnosed. Furthermore, the collaboration with Intel to run AI inference locally on hospital hardware could accelerate adoption by addressing concerns about data security and cloud dependency, making AI more practical for real-world clinical settings. As healthcare systems worldwide grapple with rising imaging volumes and workforce shortages, solutions that extract more value from existing scans without additional cost or radiation exposure are increasingly essential. Nanox's dual strategy not only advances its commercial footprint but also strengthens the technological foundation for scalable AI deployment, ultimately benefiting patients and providers alike.
Summary
Nano-X Imaging Ltd. (NASDAQ: NNOX) is advancing its medical imaging analytics strategy through two significant announcements this month, both aimed at addressing the vast amount of diagnostic information that goes unnoticed in routine CT scans. Approximately 86,000 vertebral fragility fractures occur annually in the UK, with most remaining undiagnosed. A CT scan ordered for one clinical question can capture additional anatomical information related to the spine, coronary arteries, liver, and other areas, creating an opportunity to support clinical evaluation of findings that might otherwise be missed.
To capitalize on this opportunity, Nanox.AI, the company's imaging analytics subsidiary, has signed an exclusive three-year UK reseller agreement with Vertec Scientific for its HealthOST bone solution. The deal includes minimum annual license commitments, providing a predictable revenue stream while expanding access to the technology in a key market. This commercial milestone underscores the growing demand for AI-driven tools that can extract actionable insights from existing imaging data without requiring additional scans.
In parallel, a separate optimization project with Intel demonstrates a path for Nanox.AI's imaging AI framework to run inference locally on hospital hardware rather than relying entirely on the cloud. This could enhance data privacy, reduce latency, and lower operational costs for healthcare providers. Together, these initiatives highlight Nanox's dual approach: expanding commercial reach while improving the technical infrastructure needed to deploy AI at scale. The company's latest news and updates are available in its newsroom at https://ibn.fm/NNOX.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, Nanox.AI Expands UK Reach and Local AI Inference with Intel
